TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin Meeting Abstract


Authors: Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
Abstract Title: TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019000244
PROVIDER: wos
Notes: Meeting Abstract: 180 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
MSK Authors
  1. Zhigang Zhang
    238 Zhang
  2. Joachim Yahalom
    391 Yahalom
  3. Craig Moskowitz
    367 Moskowitz
  4. Heiko Schoder
    276 Schoder
  5. Alison Moskowitz
    136 Moskowitz
  6. Martin Fleisher
    231 Fleisher
  7. Susan J McCall
    13 McCall
  8. Kaitlin Marie Woo
    97 Woo
  9. Stephanie Yvonne Fox
    5 Fox
  10. Sun Min Cho
    4 Cho